Doctors at AIIMS, Delhi are developing a low-cost antibody-based adaptive cellular therapy for treatment of multiple myeloma, a form of blood cancer.

According to latest data from National cancer registry, the estimated number of incident cases of cancer in India in 2022 was ...

Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.

Scientists have uncovered new details about the mechanism behind cancer progression. Researchers explored the influence the mechanical stiffening of the tumor cell's environment may have on the ...

Researchers have successfully developed a modular synthetic translational coupling element (SynTCE), significantly enhancing ...

Meanwhile, synthetic gel aids in recovery after spinal surgery; Pittsburgh researchers create helper robots for people with ALS; a study finds nerve stimulation is effective against ...

For CRISPR Therapeutics specifically, that financial flexibility is not necessarily needed even if it's a plus. As of the most recent quarter, Q3, it reported having around $1.9 billion in cash, ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

Taking inspiration from the mechanics of WWI aircraft, this innovation could redefine approaches to cancer and heart disease ...

PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a ...

More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset ...